Vimseltinib, sold under the brand name Romvimza, is an anti-cancer medication used for the treatment of tenosynovial giant cell tumor.Vimseltinib is a kinase inhibitor. Vimseltinib is a macrophage colony-stimulating factor receptor antagonis
| CAS No. | 1628173-05-4 |
| Molecular Weight (g/mol) | 431.5000 |
| Molecular Formula | C23H25N7O2 |